Tert-Butyl 1-Cyclobutyl-3-Hydroxypropan-2-Ylcarbamate
95%
- Product Code: 243815
CAS:
816429-99-9
Molecular Weight: | 229.32 g./mol | Molecular Formula: | C₁₂H₂₃NO₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building complex drug candidates. The hydroxyl and carbamate groups enable coupling reactions and protection strategies in multi-step organic syntheses. Commonly employed in research settings to design analogs with improved metabolic stability and target affinity.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿10,720.00 |
+
-
|
0.250 | 10-20 days | ฿17,890.00 |
+
-
|
1.000 | 10-20 days | ฿43,910.00 |
+
-
|
Tert-Butyl 1-Cyclobutyl-3-Hydroxypropan-2-Ylcarbamate
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building complex drug candidates. The hydroxyl and carbamate groups enable coupling reactions and protection strategies in multi-step organic syntheses. Commonly employed in research settings to design analogs with improved metabolic stability and target affinity.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :